AJO LP’s DexCom DXCM Stock Holding History

AJO LP’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-103,624	Closed	-$3.08M	–	661
2019 Q1	$3.08M	Sell	103,624 -3,324	-3%	-$117K	0.02%	399
2018 Q4	$3.2M	Buy	+106,948	New	+$3.39M	0.02%	388

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AJO LP's DXCM Position: Q2 2019 in Review

AJO LP sold out of DexCom (DXCM) in Q2 2019, closing a stake of 103,624 shares — an estimated $3.08M sold.

AJO LP first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $3.2M in Q4 2018. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

AJO LP reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
AJO LP sold 103,624 DexCom shares in Q2 2019, an estimated $3.08M.
AJO LP first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
AJO LP's DexCom position peaked at $3.2M in Q4 2018.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on AJO LP's 13F filing for Q2 2019, filed 14 Aug 2019.